Institutional Ownership
Harvard Bioscience Inc
CUSIP 416906204COMQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
30
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Weber Capital Management LLC /Adv | 320.0K | $1.56M |
| 2 | Corsair Capital Management, L.P. | 124.8K | $607.8K |
| 3 | Two Sigma Investments, LP | 114.1K | $555.8K |
| 4 | Renaissance Technologies LLC | 101.4K | $493.9K |
| 5 | Blackrock, Inc. | 62.2K | $303.0K |
| 6 | Geode Capital Management, LLC | 59.5K | $289.9K |
| 7 | Millennium Management LLC | 46.3K | $225.6K |
| 8 | Williams & Novak, LLC | 27.1K | $137.7K |
| 9 | Essex Investment Management Co LLC | 27.0K | $131.6K |
| 10 | Jane Street Group, LLC | 23.8K | $116.1K |